NCT03273244View on ClinicalTrials.gov

Measuring Comfort During Palliative Sedation

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

September 30, 2019

Conditions
Palliative Sedation
Interventions
DEVICE

NeuroSense monitoring and ANI monitoring

From the start of palliative sedation, monitoring of EEG with NeuroSense device (WAVcns: Wavelet Anesthetic Value of the Central Nervous System) and ANI-monitoring (Analgesia Nociception Index) will be initiated.

Trial Locations (2)

1090

University Hospital, Brussels

9200

Algemeen Ziekenhuis Sint-Blasius, Dendermonde

All Listed Sponsors
lead

Vrije Universiteit Brussel

OTHER

NCT03273244 - Measuring Comfort During Palliative Sedation | Biotech Hunter | Biotech Hunter